STAT+: Lawmakers revive legislation to accelerate the development of new antibiotics

After months of anticipation, a bipartisan group of U.S. lawmakers is reintroducing bills in the Senate and the House that supporters hope will jump-start the development of novel antibiotics to combat drug-resistant bacteria.

The legislation, called the PASTEUR Act, would provide upfront payments anywhere from $750 million to $3 billion to a drug developer in exchange for unlimited access to its antibiotic. The “subscription model” would enable drug companies to recover their investments in research and development and make an appropriate profit without having to sell large amounts of antibiotics to survive financially.

Continue to STAT+ to read the full story…

Source link


The leading source for trustworthy and timely health and medical news and information. Providing credible health information, supportive community, and educational services by blending award-winning expertise in content, community services, expert commentary, and medical review. Everything about health is here with the difference of Dr.About

Related Articles

Leave a Reply

Back to top button